Published: 25-03-2020 14:50 | Updated: 25-03-2022 13:42
First collaboration between partners in the NextGenNK competence center
Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies. NextGenNK catalyzed interaction among its industrial partners to advance NK cell-based immunotherapies